Start Date
December 31, 2025
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
Tenofovir (TDF) and Emtricitabine (FTC)
"Tenofovir (TDF): a nucleotide reverse transcriptase inhibitor (NtRTI) an acyclic nucleotide analog of adenosine 5'-monophosphate. This is used in children as young as age 2.~Emtricitabine (FTC): a nucleoside reverse transcriptase inhibitor (NRTI), a synthetic analog of cytidine which binds at the active site of the reverse transcriptase."
Placebo
Placebo for Tenofovir and Placebo for Emtricitabine
Collaborators (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Human Genome Research Institute (NHGRI)
NIH
Gilead Sciences
INDUSTRY
Emerson Resources
UNKNOWN
National Institutes of Health (NIH)
NIH
Children's Hospital of Philadelphia
OTHER